BioAge Labs, Inc. BIOA

Set alert

5.96 USD +0.16 (+2.76%)

At closeNov 3, 2026, 4:00 PM EST

5.96 0.00 0.00%

After hours · Nov 3, 4:00 PM ET

5.58 Day range 6.01

4.81 52-week range 25.96

Held by insiders 2.44%

Held by institutions 85.48%

Float held by institutions 87.61%

Institutions 192

Top institutional holders
Holder	% held	Shares	Value	Reported
a16z Capital Management, L.L.C.	7.27%	3,233,170	80.47M	Mar 30, 2026
Cormorant Asset Management, LP	6.50%	2,890,605	71.95M	Mar 30, 2026
Sofinnova Investments, Inc.	5.16%	2,293,788	57.09M	Mar 30, 2026
Blackrock Inc.	5.10%	2,267,756	56.44M	Mar 30, 2026
Janus Henderson Group PLC	4.71%	2,094,270	52.13M	Mar 30, 2026
Octagon Capital Advisors LP	3.93%	1,748,000	43.51M	Mar 30, 2026

Top mutual fund holders
Holder	% held	Shares	Value	Reported
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund	2.22%	985,493	24.53M	Mar 30, 2026
iShares Trust-iShares Russell 2000 ETF	1.63%	725,323	18.05M	May 30, 2026
VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund	0.76%	336,229	8.37M	Mar 30, 2026
Fidelity Salem Street Trust-Fidelity Small Cap Index Fund	0.67%	298,933	7.44M	Apr 29, 2026
iShares Trust-iShares Russell 2000 Value ETF	0.60%	264,819	6.59M	May 30, 2026
SPDR SERIES TRUST-State Street SPDR S&P Pharmaceuticals ETF	0.51%	228,473	5.69M	May 30, 2026

BIOA insiders
Insider	Relation	Latest transaction	Date	Shares held
BARTON SHANE	Officer	Sale	Jun 29, 2026	0
CORMORANT ASSET MANAGEMENT ,L.P	Unknown	Purchase	Sep 26, 2024	0
ENRIGHT PATRICK G.	Director	Purchase	Sep 26, 2024	0
FORTNEY KRISTEN	Chief Executive Officer	Sale	Jan 12, 2026	976,949
GOLDSTEIN DOV A	Chief Financial Officer	Conversion of Exercise of derivative security	Apr 22, 2026	36,575
HEALY JAMES I	Director	Purchase	Sep 26, 2024	0

Held by funds